UBS Group AG - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$75,025
-19.3%
9,990
-5.1%
0.00%
Q2 2023$92,998
+1485.6%
10,532
+1393.9%
0.00%
Q1 2023$5,865
+855.2%
705
+1001.6%
0.00%
Q4 2022$614
-97.6%
64
-97.9%
0.00%
Q3 2022$26,0003,099
+4742.2%
0.00%
Q2 2022$0
-100.0%
64
-94.2%
0.00%
Q1 2022$6,000
-82.4%
1,096
-85.9%
0.00%
Q4 2021$34,000
+3300.0%
7,777
+12051.6%
0.00%
Q3 2021$1,000
-99.8%
64
-99.9%
0.00%
Q2 2021$430,000
+70.6%
58,986
+45.4%
0.00%
Q1 2021$252,000
+869.2%
40,569
+1042.8%
0.00%
Q4 2020$26,000
-55.2%
3,550
-48.5%
0.00%
Q2 2020$58,000
+866.7%
6,887
+600.6%
0.00%
Q4 2019$6,000
-45.5%
983
-57.3%
0.00%
Q3 2019$11,0002,302
+2051.4%
0.00%
Q2 2019$0
-100.0%
107
-65.6%
0.00%
Q1 2019$2,000
-95.7%
311
-95.7%
0.00%
Q4 2018$46,000
+100.0%
7,195
+157.1%
0.00%
Q3 2018$23,000
-48.9%
2,799
-34.8%
0.00%
Q2 2018$45,000
+462.5%
4,293
+428.0%
0.00%
Q4 2017$8,000
+700.0%
813
+929.1%
0.00%
Q3 2017$1,000790.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders